Loading Events

Go Back

event image

6th Annual Global Summit on Hematologic Malignancies

March 13 - 17, 2019

OVERVIEW

Oncology Meeting Innovations’ 6th Annual Summit on Hematologic Malignancies fosters discussion and debate on the evolution of treatment of hematologic malignancies and features a focused approach towards individual patient populations through case-based discussions. In response to changes in the clinical landscape of chronic lymphocytic leukemia, multiple myeloma, lymphomas and acute leukemias, the summit assembles translational researchers, clinical researchers and key community oncologists to address the challenges of this rapidly evolving area of oncology.

KEY TOPICS

  • How new agents targeting BTK, PI3K delta and BCL-2, as well as next-generation CD20 monoclonal antibodies are changing the landscape and treatment paradigms for CLL
  • Treatment advances in multiple myeloma including recent data on drugs targeting CD38, SLAMF7, and HDAC in addition to novel approaches to proteasome inhibition
  • Identifying and analyzing advances in the understanding of the molecular biology and microenvironment in treating lymphoma and acute leukemia
  • Novel strategies such as chimeric antigen receptor T-cell therapy, checkpoint inhibition and next-generation antibody therapy in treating hematologic malignancies

 

PROGRAM CHAIRS

6th Annual Global Summit on Hematologic Malignancies

Steven Coutre, MD

Professor of Medicine Stanford University Stanford, CA

6th Annual Global Summit on Hematologic Malignancies

Andrew Zelentz, MD, PhD

Medical Director, Quality Informatics Memorial Sloan Kettering Cancer Center New York, NY

6th Annual Global Summit on Hematologic Malignancies

Richard Stone, MD

Professor of Medicine Director, Translational Research, Adult Leukemia Program Dana-Farber Cancer Institute/Harvard Medical School Boston, MA

6th Annual Global Summit on Hematologic Malignancies

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor, Applied Cancer Research and Drug Discovery Translational Genomics Research Institute at City of Hope Duarte, CA

ACCOMMODATIONS

Fairmont Chateau Whistler

Fairmont Chateau Whistler

The Fairmont Chateau is Whistler’s landmark ski-in ski-out hotel and British Columbia golf resort. Combining classic elegance and a modern alpine setting, this award-winning hotel showcases exceptional dining and full resort amenities including a par 72, 18-hole Audubon-certified championship golf course. 

The Fairmont Chateau Whistler is sold out during the dates of the summit. OMI recommends the Westin Whistler or Glacier Lodge as alternative accommodations.